35 Results

People

  1. Panageas
    Panageas
  2. Houghton
    Houghton
  3. Chapman
    Chapman
  4. Livingston
    Livingston
  5. Begg
    Begg
  6. Krown
    Krown
  7. Wolchok
    Wolchok
  8. Hricak
    Hricak
  9. Moskowitz
    Moskowitz
  10. Williams
    Williams

Groups

  1. Biostatistics Service (35)
  2. Department of Medicine (35)
  3. Epidemiology and Biostatistics (35)
  4. Population Sciences Research Program (35)
  5. Sloan Kettering Institute Faculty (35)
  6. Solid Tumor Oncology Division (35)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (27)
  8. Molecular Pharmacology and Chemistry Program Faculty (22)
  9. GSK Faculty (21)
  10. Melanoma and Immunotherapeutics Service (18)
  1. "Biostatistics Service"
  2. "Population Sciences Research Program"
  3. "Sloan Kettering Institute Faculty"
  4. "Solid Tumor Oncology Division"
  5. "adult"
Formats
  1. Journal Article (35)
Groups
  1. Biostatistics Service (35)
  2. Department of Medicine (35)
  3. Epidemiology and Biostatistics (35)
  4. Population Sciences Research Program (35)
  5. Sloan Kettering Institute Faculty (35)
  6. Solid Tumor Oncology Division (35)

More Groups

People
  1. Katherine Panageas (19)
  2. Paul Chapman (15)
  3. Alan Houghton (14)
  4. Philip Livingston (10)
  5. Jedd Wolchok (9)
  6. Colin Begg (8)

More People

Years
  1. 2017 (1)
  2. 2015 (1)
  3. 2014 (1)
  4. 2013 (3)
  5. 2012 (1)
  6. 2011 (1)

More Years

Publications
  1. Clinical Cancer Research (7)
  2. Journal of Clinical Oncology (5)
  3. Radiology (4)
  4. Cancer (3)
  5. American Journal of Roentgenology (1)
  6. Annals of Surgery (1)

More Publications

Publishers
  1. American Association for Cancer Research (9)
  2. American Society of Clinical Oncology (6)
  3. Radiological Society of North America, Inc. (4)
  4. Wiley Blackwell (3)
  5. Elsevier Science, Inc. (2)
  6. Oxford University Press (2)

More Publishers

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma
    Journal Article

    Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • A retrospective evaluation of vemurafenib as treatment for BRAF-mutant melanoma brain metastases
    Journal Article

    Harding, J. J.; Catalanotti, F.; Munhoz, R. R.; Cheng, D. T.; Yaqubie, A.; Kelly, N.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Lacouture, M. E.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma
    Journal Article

    O'Reilly, E. M.; Perelshteyn, A.; Jarnagin, W. R.; Schattner, M.; Gerdes, H.; Capanu, M.; Tang, L. H.; Lavalle, J.; Winston, C.; DeMatteo, R. P.; more...
    Annals of Surgery (2014)

    Fulltext@MSK | Save
  • Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Adamow, M.; Mu, Z.; Tandon, S.; Hannaman, D.; Chapman, P.; Schwartz, G.; Carvajal, R.; Panageas, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report
    Journal Article

    Bernstein, J. L.; Thomas, D. C.; Shore, R. E.; Robson, M.; Boice, J. D. Jr; Stovall, M.; Andersson, M.; Bernstein, L.; Malone, K. E.; Reiner, A. S.; more...
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma
    Journal Article

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery
    Journal Article

    Lakhman, Y.; Akin, O.; Sohn, M. J.; Zheng, J.; Moskowitz, C. S.; Iyer, R. B.; Barakat, R. R.; Sabbatini, P. J.; Chi, D. S.; Hricak, H.
    American Journal of Roentgenology (2012)

    Fulltext@MSK | Save
  • (124)I-huA33 antibody PET of colorectal cancer
    Journal Article

    Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy
    Journal Article

    Zakian, K. L.; Hricak, H.; Ishill, N.; Reuter, V. E.; Eberhardt, S.; Moskowitz, C. S.; Shukla-Dave, A.; Wang, L.; Scardino, P. T.; Eastham, J. A.; more...
    Journal of Urology (2010)

    Fulltext@MSK | Save
  • Immunologic response to xenogeneic gp100 DNA in melanoma patients: Comparison of particle-mediated epidermal delivery with intramuscular injection
    Journal Article

    Ginsberg, B. A.; Gallardo, H. F.; Rasalan, T. S.; Adamow, M.; Mu, Z.; Tandon, S.; Bewkes, B. B.; Roman, R. A.; Chapman, P. B.; Schwartz, G. K.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save